glutathione and multiple myeloma Lipid metabolic vulnerabilities of | Clinical Experimental Medicine A myeloma-targeting monoclonal antibody offers
A myeloma targeting monoclonal antibody offers new hope for treating multiple myeloma EurekAlert! The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Blood Cancer Journal What Is Multiple Myeloma and How Can It Be Managed? Metabolic Alterations in Multiple Myeloma: From Oncogenesis to Proteasome Inhibitor Resistance
Pay in 4 interest-free payments of $6.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6


